
A man with prostate cancer who takes the “watch-and-wait” approach has the same long-term survival odds as those who undergo radiation therapy or surgery, according to a new large-scale study. Patients had the same 97% survival rate after a decade and a half whether doctors treated their tumor or simply put it under observation, British researchers found. “Survival from prostate cancer was high after 15 years of follow-up, whether patients received radiotherapy, prostatectomy [prostate removal] or active monitoring,” said study co-author Jenny Donovan, a professor of social medicine with the University of Bristol. “Only 3% of patients in the study died from prostate cancer.” Researchers presented the findings last weekend at the European Association of Urology’s annual meeting, in Milan, and the results were published simultaneously in the New England Journal of Medicine. For the study, researchers evaluated nearly 82,500 men in the United Kingdom who underwent a prostate-specific antigen (PSA) test between 1999 and 2009. The study recruited just over 1,600 men diagnosed with localized prostate cancer as a result of their screening and randomly assigned them to one of three groups — an active monitoring group, a group that underwent surgery to remove their prostate, and a group that received radiation therapy for their cancer. After 15 years, only 45 had died — 17 in the active monitoring group, 12 in the surgery… read on > read on >